Drugs and Mental Health

November 20, 1957

Report Outline
Benefits and Risks in Use of Tranquilizers
Drug Therapy for Mentally ILL Persons
Relation of Physical to Mental Illness

Benefits and Risks in Use of Tranquilizers

Rapidly spreading use of tranquilizing drugs has aroused considerable concern among medical leaders. They feel that more time and study are needed to weigh the effects of the drugs on human beings. They tend to look on the current predilection for “happiness pills” as a medical fad, for they strongly suspect that the drugs are being prescribed for not a few individuals who receive no benefit from them and who may even be harmed.

Early enthusiasm for one or another of the drugs as a “miracle” specific for severe mental illness is being tempered by the more cautious reports of later investigators. Although the tranquilizers continue to be regarded as useful in the care and treatment of mental patients, hope is fading that they will bring about a drastic reduction in the number of persons afflicted. The attention paid to the drugs, however, has had the important indirect result of stimulating research into the basic causes of mental disease. Studies of the action of tranquilizing drugs on the brain have opened new avenues for exploring the connections between mind and body, which may help to establish a physiological basis for mental illness.

Meanwhile, two agencies of the federal government are making concerted efforts to assemble full and dependable information on the efficacy of particular drugs in particular medical situations, on hazards involved in their use, on appropriate dosages, and other data necessary for safe and effective use of the drugs in medical practice. The National Institute of Mental Health of the U.S. Public Health Service and the Veterans Administration, which cares for 60,000 hospitalized neuropsychiatric patients, are taking the lead in pressing these investigations.

ISSUE TRACKER for Related Reports
Mental Health
Mar. 24, 2023  Aging and Mental Health
Jul. 01, 2022  Youth Mental Health
Jul. 31, 2020  COVID-19 and Mental Health
Oct. 11, 2019  The Insanity Defense
Jul. 12, 2019  Suicide Crisis
Mar. 13, 2015  Prisoners and Mental Illness
Dec. 05, 2014  Treating Schizophrenia
Sep. 12, 2014  Teen Suicide
May 10, 2013  Mental Health Policy
Aug. 03, 2012  Treating ADHD
Jun. 01, 2012  Traumatic Brain Injury
Jun. 26, 2009  Treating Depression
Feb. 13, 2004  Youth Suicide
Feb. 06, 2004  Mental Illness Medication Debate
Mar. 29, 2002  Mental Health Insurance
Feb. 08, 2002  Treating Anxiety
Jul. 16, 1999  Childhood Depression
Jun. 18, 1999  Boys' Emotional Needs
Sep. 12, 1997  Mental Health Policy
Aug. 19, 1994  Prozac
Aug. 06, 1993  Mental Illness
Oct. 09, 1992  Depression
Jun. 14, 1991  Teenage Suicide
Jul. 08, 1988  Biology Invades Psychology
Feb. 13, 1987  The Mentally Ill
Aug. 20, 1982  Mental Health Care Reappraisal
Jun. 12, 1981  Youth Suicide
Sep. 21, 1979  Mental Health Care
Sep. 15, 1978  Brain Research
Jul. 05, 1974  Psychomedicine
Aug. 08, 1973  Emotionally Disturbed Children
Dec. 27, 1972  Mental Depression
Mar. 24, 1972  Schizophrenia: Medical Enigma
Apr. 21, 1971  Approaches to Death
Mar. 03, 1971  Encounter Groups
Nov. 25, 1970  Psychological Counseling of Students
Feb. 19, 1969  Future of Psychiatry
Feb. 02, 1966  New Approaches to Mental Illness
Jan. 22, 1964  Insanity as a Defense
Sep. 25, 1963  Anatomy of Suicide
Nov. 20, 1957  Drugs and Mental Health
Apr. 23, 1954  Mental Health Programs
Jul. 09, 1948  Mental Health
BROWSE RELATED TOPICS:
Mental Health
Pharmaceuticals